Expression of Simian Virus 40 T antigens in Intestine
猿猴病毒40 T抗原在肠道中的表达
基本信息
- 批准号:7231473
- 负责人:
- 金额:$ 30.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-07-01 至 2008-04-30
- 项目状态:已结题
- 来源:
- 关键词:AgeAntigen TargetingAntigensApoptosisBindingCarcinomaCell CycleCell DeathCell ProliferationCellsCessation of lifeComplexCyclin ADevelopmentDysplasiaEnterocytesExhibitsFamilyGenesGenetic TranscriptionGoalsGrowthHyperplasiaIntestinal Intraepithelial NeoplasiaIntestinesLarge T AntigenLeadLengthMesenchymeMusMutationNumbersOncogene ProteinsPathway interactionsPatternPhasePhosphoric Monoester HydrolasesPlayPopulationProliferatingProtein p53ProteinsRangeRegulationRepressionResearch PersonnelRetinoblastoma ProteinRoleSeriesSimian virus 40Small T AntigenStem cellsSystemTP53 geneTissuesTranscriptional ActivationTransgenic MiceTransgenic OrganismsTumor Suppressor ProteinsVillusViral Tumor AntigensViruscell growthcell typecellular targetinggenetic regulatory proteinintestinal cryptintestinal villimRNA Expressionmembermutantnovelresearch studyresponsesialosyl-T antigensizetooltranscription factortumorigenesis
项目摘要
DESCRIPTION (provided by applicant): We have been using the 708 large T antigen encoded by simian virus 40 (SV40) to probe mechanisms of cell proliferation and death. T antigen is sufficient to induce transformation in a number of cell-types in culture. However, in transgenic mouse systems the effect of T antigen expression is cell-type dependent with responses ranging from induction of hyperplasia or carcinoma to cell death. Furthermore, T antigen possesses multiple transforming functions and which function(s) is(are) required for transformation also depends on the cell-type. We have been studying the mouse intestine to explore the regulation of cellular growth control. The intestine consists of the crypts, which contain stem cells and a proliferating cell population, and the villi, which are composed of growth-arrested, terminally differentiated cells. Expression of large T antigen in enterocytes induces their reentry into the cell cycle resulting in an intestinal hyperplasia that is dependent upon the interaction of T antigen with the Rb-family of tumor suppressors. Furthermore, an amino-terminal fragment of T antigen (dl1137) that inactivates Rb but is missing the p53 interaction domain, also induces hyperplasia. We conclude that the induction of enterocyte proliferation requires an interaction of T antigen with one or more members of the Rb-family. Interestingly, while the intestines of mice expressing dl1137 remain at hyperplasia, those expressing wild-type T antigen progress with age to dysplasia. Thus, dysplasia requires carboxy-terminal of T antigen. We have shown that T antigen interaction with p53 does not play a role in either induction of hyperplasia or dysplasia. In this application, we seek to: (1) understand the mechanism of T antigen-induced hyperplasia; and, (2) identify the T antigen target and cellular pathway(s) required for progression to dysplasia.
描述(由申请人提供):我们一直在使用由猿猴病毒40(SV 40)编码的708大T抗原来探测细胞增殖和死亡的机制。T抗原足以在培养物中的许多细胞类型中诱导转化。然而,在转基因小鼠系统中,T抗原表达的作用是细胞类型依赖性的,反应范围从诱导增生或癌细胞死亡。此外,T抗原具有多种转化功能,并且转化所需的功能也取决于细胞类型。我们一直在研究小鼠肠道,以探索细胞生长控制的调节。肠由含有干细胞和增殖细胞群的隐窝和由生长停滞的终末分化细胞组成的绒毛组成。肠上皮细胞中大T抗原的表达诱导它们重新进入细胞周期,导致肠增生,这依赖于T抗原与Rb家族的肿瘤抑制因子的相互作用。此外,使Rb失活但缺失p53相互作用结构域的T抗原的氨基末端片段(dl 1137)也诱导增生。我们得出结论,肠上皮细胞增殖的诱导需要T抗原与Rb家族的一个或多个成员的相互作用。有趣的是,虽然表达dl 1137的小鼠的肠道仍处于增生状态,但表达野生型T抗原的小鼠随着年龄的增长而发育不良。因此,发育异常需要T抗原的羧基末端。我们已经表明,T抗原与p53的相互作用不起作用,无论是诱导增生或异型增生。在本申请中,我们寻求:(1)了解T抗原诱导的增生机制;和(2)鉴定进展为发育不良所需的T抗原靶标和细胞途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES M PIPAS其他文献
JAMES M PIPAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES M PIPAS', 18)}}的其他基金
Manipulation of innate immunity by Polyomavirus T antigens
多瘤病毒 T 抗原操纵先天免疫
- 批准号:
10401454 - 财政年份:2020
- 资助金额:
$ 30.87万 - 项目类别:
Analysis of cellular factors limiting productive JC virus infections
限制生产性 JC 病毒感染的细胞因素分析
- 批准号:
10312804 - 财政年份:2020
- 资助金额:
$ 30.87万 - 项目类别:
Manipulation of innate immunity by Polyomavirus T antigens
多瘤病毒 T 抗原操纵先天免疫
- 批准号:
10030247 - 财政年份:2020
- 资助金额:
$ 30.87万 - 项目类别:
Manipulation of innate immunity by Polyomavirus T antigens
多瘤病毒 T 抗原操纵先天免疫
- 批准号:
10196991 - 财政年份:2020
- 资助金额:
$ 30.87万 - 项目类别:
Manipulation of innate immunity by Polyomavirus T antigens
多瘤病毒 T 抗原操纵先天免疫
- 批准号:
10621762 - 财政年份:2020
- 资助金额:
$ 30.87万 - 项目类别:
Exploring viral infection with single cell transcriptomics
用单细胞转录组学探索病毒感染
- 批准号:
9285734 - 财政年份:2016
- 资助金额:
$ 30.87万 - 项目类别:
Exploring viral infection with single cell transcriptomics
用单细胞转录组学探索病毒感染
- 批准号:
9167182 - 财政年份:2016
- 资助金额:
$ 30.87万 - 项目类别:
Regulation of cellular functions by two human Polyomaviruses
两种人类多瘤病毒对细胞功能的调节
- 批准号:
9088664 - 财政年份:2016
- 资助金额:
$ 30.87万 - 项目类别:
Regulation of Transcription and Translation by Human Polyomaviruses
人类多瘤病毒的转录和翻译调控
- 批准号:
8849838 - 财政年份:2014
- 资助金额:
$ 30.87万 - 项目类别:
Regulation of Transcription and Translation by Human Polyomaviruses
人类多瘤病毒的转录和翻译调控
- 批准号:
8768850 - 财政年份:2014
- 资助金额:
$ 30.87万 - 项目类别:
相似海外基金
Development of novel ABO blood group antigen targeting peptide that suppress rejection during ABO-incompatible kidney transplantation
开发新型 ABO 血型抗原靶向肽,可抑制 ABO 不相容肾移植过程中的排斥反应
- 批准号:
23791736 - 财政年份:2011
- 资助金额:
$ 30.87万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Antigen Targeting in plasmazytoide dendritische Zellen - Nutzung zur Toleranzinduktion und Vakzinierung
浆细胞样树突状细胞中的抗原靶向 - 用于耐受诱导和疫苗接种
- 批准号:
211908646 - 财政年份:2011
- 资助金额:
$ 30.87万 - 项目类别:
Research Grants
Development of Novel Prostate Specific Membrane Antigen Targeting Probes for Prostate Cancer Imaging
开发用于前列腺癌成像的新型前列腺特异性膜抗原靶向探针
- 批准号:
23791413 - 财政年份:2011
- 资助金额:
$ 30.87万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Immunregulation bei entzündlichen Darmerkrankungen durch Antigen Targeting des DEC-205 Rezeptors - Mechanismen und Funktion
通过 DEC-205 受体抗原靶向调节炎症性肠病 - 机制和功能
- 批准号:
168824599 - 财政年份:2010
- 资助金额:
$ 30.87万 - 项目类别:
Research Grants
Anti-tumor vaccine by the use of antigen targeting to lectins expressed on dendritic cells
利用抗原靶向树突状细胞上表达的凝集素的抗肿瘤疫苗
- 批准号:
21790144 - 财政年份:2009
- 资助金额:
$ 30.87万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Development of novel oncofetal antigen targeting immunotherapy for refractory ovarian carcinoma
难治性卵巢癌新型癌胎抗原靶向免疫疗法的开发
- 批准号:
21592127 - 财政年份:2009
- 资助金额:
$ 30.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Salmonella type III-mediated antigen targeting to induce cellular immunity: characterzition of effector and memory T cell populations after oral vaccination
沙门氏菌 III 型介导的抗原靶向诱导细胞免疫:口服疫苗接种后效应和记忆 T 细胞群的特征
- 批准号:
5265936 - 财政年份:2000
- 资助金额:
$ 30.87万 - 项目类别:
Priority Programmes
TB ANTIGEN TARGETING TO ENHANCE T CELL RESPONSE
靶向结核抗原以增强 T 细胞反应
- 批准号:
2882120 - 财政年份:1999
- 资助金额:
$ 30.87万 - 项目类别:
TB ANTIGEN TARGETING TO ENHANCE T CELL RESPONSE
靶向结核抗原以增强 T 细胞反应
- 批准号:
2413472 - 财政年份:1998
- 资助金额:
$ 30.87万 - 项目类别: